Is This MRSA We See Before Us? | GenomeWeb

Tech Review highlights a test from Adnavance that can detect methicillin-resistant Staphylococcus aureus without culturing the bacteria or amplifying the DNA. Instead, the Adnavance test is built on top of a gold electrode that is covered with a proprietary marker. The marker binds MRSA and when a current flows through the gold electrode, it attracts the DNA. CEO Randy White says they plan to launch the test in 2011 at a price of about $60.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.